| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06663332 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants |
Trial sites expanded: 42 -> 47 locations |
| 2026-06-12 | NCT06663332 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants |
date change Completion pushed: 2031-12-12 -> 2032-02-25 |
| 2026-06-12 | NCT06532032 A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With… |
Trial completed |
| 2026-06-10 | NCT07443215 Evaluation of Effect of Scatter on Visual Performance |
Trial completed |
| 2026-06-10 | NCT07443215 Evaluation of Effect of Scatter on Visual Performance |
Enrollment reduced: 36 -> 31 participants |
| 2026-06-09 | NCT03301220 A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With… |
Trial completed |
| 2026-06-09 | NCT03301220 A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With… |
date change Completion moved earlier: 2026-06-30 -> 2026-05-04 |
| 2026-06-09 | NCT02908906 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity… |
Enrollment reduced: 413 -> 234 participants |
| 2026-06-09 | NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… |
Recruitment opened |
| 2026-06-09 | NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… |
Trial sites expanded: 0 -> 6 locations |
| 2026-06-09 | NCT07577843 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease |
Recruitment opened |
| 2026-06-09 | NCT07577843 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease |
Trial sites expanded: 0 -> 5 locations |
| 2026-06-06 | NCT06260163 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… |
date change Primary completion moved earlier: 2028-05-22 -> 2027-02-10 |
| 2026-06-06 | NCT06260163 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… |
date change Completion moved earlier: 2028-08-14 -> 2027-04-28 |
| 2026-06-06 | NCT07227454 A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of… |
Trial sites expanded: 9 -> 27 locations |
| 2026-06-06 | NCT07196748 A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to… |
Trial sites expanded: 385 -> 393 locations |
| 2026-06-06 | NCT04722146 A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple… |
date change Primary completion moved earlier: 2027-04-07 -> 2025-10-13 |
| 2026-06-06 | NCT05421663 A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma |
date change Completion pushed: 2029-03-12 -> 2041-07-30 |
| 2026-06-06 | NCT05438043 A Study of Daratumumab |
date change Completion pushed: 2029-01-31 -> 2029-12-31 |
| 2026-06-06 | NCT07258485 A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07615426 A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment… | Phase 1 | Recruiting |
| 2026-05-26 | NCT07606339 A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis | Not Yet Recruiting | |
| 2026-05-22 | NCT07602088 A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for… | Recruiting | |
| 2026-05-15 | NCT07589634 A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release… | Phase 2 | Not Yet Recruiting |
| 2026-05-14 | NCT07586202 A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05201781 | A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel | Multiple Myeloma | Recruiting |
| NCT07030517 | A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and… | Multiple Myeloma | Recruiting |
| NCT07053345 | A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant… | Depressive Disorder, Treatment-Resistant | Recruiting |
| NCT07141004 | A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants… | Arthritis, Psoriatic | Recruiting |
| NCT07310095 | A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's… | Crohn Disease | Recruiting |
| NCT04108208 | A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant… | Prostatic Neoplasms | Active, Not Recruiting |
| NCT04929210 | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active… | Arthritis, Psoriatic | Active, Not Recruiting |
| Phase 3 | |||
| NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Myasthenia Gravis | Recruiting |
| NCT01804686 | A Long-term Extension Study of PCI-32765 (Ibrutinib) | Chronic Lymphocytic Leukemia | Recruiting |
| NCT04892173 | JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC | Carcinoma, Squamous Cell | Recruiting |
| NCT05438043 | A Study of Daratumumab | Multiple Myeloma | Recruiting |
| NCT05552222 | A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and… | Multiple Myeloma | Recruiting |
| NCT05912517 | A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus… | Hemolytic Disease of the Fetus and Newborn | Recruiting |
| NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… | Crohn's Disease | Recruiting |
| NCT06208150 | A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and… | Multiple Myeloma | Recruiting |
| NCT06319820 | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT06449651 | A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune… | Thrombocytopenia, Neonatal Alloimmune | Recruiting |
| NCT06533098 | A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of… | Thrombocytopenia, Neonatal Alloimmune | Recruiting |
| NCT06559306 | Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants… | Depressive Disorder, Major | Recruiting |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… | Colorectal Neoplasms | Recruiting |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… | Colorectal Neoplasms | Recruiting |
| NCT06807424 | A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in… | Arthritis, Psoriatic | Recruiting |
| NCT06852222 | A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… | Leukemia, Myeloid, Acute | Recruiting |
| NCT06919965 | A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT07164443 | A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant… | Metastatic Castration-resistant Prostate Neoplasms | Recruiting |